Envestnet Asset Management
CDMO

Envestnet Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Envestnet Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,350
Closed -$118K – 4431
2024
Q3 		$118K Buy
+10,350
New +$104K ﹤0.01% 4110
2023
Q4 		– Sell
-55,375
Closed -$523K – 4193
2023
Q3 		$523K Sell
55,375
-1,816
-3% -$21.9K ﹤0.01% 3225
2023
Q2 		$799K Sell
57,191
-2,828
-5% -$48.2K ﹤0.01% 2913
2023
Q1 		$1.13M Buy
60,019
+9,506
+19% +$156K ﹤0.01% 2588
2022
Q4 		$696K Sell
50,513
-11,524
-19% -$177K ﹤0.01% 2897
2022
Q3 		$1.19M Buy
62,037
+4,598
+8% +$83.8K ﹤0.01% 2425
2022
Q2 		$877K Buy
57,439
+3,701
+7% +$54.7K ﹤0.01% 2701
2022
Q1 		$1.09M Buy
53,738
+38,786
+259% +$790K ﹤0.01% 2600
2021
Q4 		$436K Buy
+14,952
New +$428K ﹤0.01% 3151
2014
Q4 		– Sell
-87
Closed -$1K – 2741
2014
Q3 		$1K Buy
+87
New +$974 ﹤0.01% 2667

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Envestnet Asset Management's CDMO Position: Q4 2024 in Review

Envestnet Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 10,350 shares — an estimated $118K sold.

Envestnet Asset Management first reported a position in CDMO in Q3 2014 and held it in 10 quarters. The position peaked at $1.19M in Q3 2022. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Envestnet Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 10,350 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $118K.
  • Envestnet Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2014 and held it in 10 quarters.
  • Envestnet Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $1.19M in Q3 2022.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Envestnet Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.